Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

<p>Drug Screening Data</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Gerhard Jungwirth (15047922) (author)
Altres autors:	Tao Yu (15047925) (author), Fang Liu (15047928) (author), Junguo Cao (15047931) (author), Montadar Alaa Eddine (15047934) (author), Mahmoud Moustafa (15047937) (author), Amir Abdollahi (15026702) (author), Rolf Warta (15047940) (author), Andreas Unterberg (15047943) (author), Christel Herold-Mende (15047946) (author)
Publicat:	2025
Matèries:	Cancer Therapeutic Research and Development CNS Cancers Small Molecule Agents Translational Research
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Elamipretide: First Approval
per: Matt Shirley (7340599)
Publicat: (2025)

Imlunestrant: First Approval
per: Susan J. Keam (6594447)
Publicat: (2025)

Data Sheet 1_LED light spectra influence the stimulation of mycelial growth and anticancer activity in Hericium erinaceus mycelium.pdf
per: Preuk Chutimanukul (12463213)
Publicat: (2025)

Male aggressiveness does not explain the frequency of reversed sexual cannibalism
per: Narmin I. Beydizada (22680192)
Publicat: (2025)

Table 1_In-silico pharmacological insights into the therapeutic potential of microRNAs for microplastic-associated cancers.docx
per: Akmaral Baspakova (17961710)
Publicat: (2025)

Supplementary data: Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US
per: Chuka Udeze (22674655)
Publicat: (2025)

Supplementary file 1_Harnessing marine algal polysaccharides for combination cancer therapy: pharmacological mechanisms and clinical perspectives.docx
per: Jing Zhong (230059)
Publicat: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
per: Lixuan Wei (14962431)
Publicat: (2025)

Supplementary Table S3 from Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects
per: Noboru Ishiyama (15146993)
Publicat: (2025)

Supplementary file 1_Single non-pharmacological intervention of depression in the elderly with cognitive dysfunction: a systematic review and network meta-analysis.docx
per: Zhengyi Tan (22681175)
Publicat: (2025)

Supplementary file 2_Single non-pharmacological intervention of depression in the elderly with cognitive dysfunction: a systematic review and network meta-analysis.docx
per: Zhengyi Tan (22681175)
Publicat: (2025)

Pharmacology in silico: rMS-induced LTP depends on dendritic sodium and calcium through voltage-gated calcium channels, as well as synaptic NMDA channels.
per: Nicholas Hananeia (22683665)
Publicat: (2025)

Characterization of a Novel Porcine Circovirus Type 2a Sequence and Anti-Viral Evaluation of Matrine and Sanguinarine Combined with Network Pharmacology and Molecular Docking
per: WENTING Qiao (22587494)
Publicat: (2025)

Table 1_Integrative network pharmacology, transcriptomics, and microbiomics elucidate the therapeutic mechanism of Polygala tenuifolia Willd water extract in chronic obstructive pulmonary disease.docx
per: Yiming An (2746240)
Publicat: (2025)

Supplementary Figures 1 from Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
per: Luana Guimaraes Sousa (16534377)
Publicat: (2025)

Suppl Data 2 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
per: Marija Pizurica (17060224)
Publicat: (2025)

Suppl. Data 1 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
per: Marija Pizurica (17060224)
Publicat: (2025)

Supplementary Tables S1-5 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL
per: Yiming Wu (15306005)
Publicat: (2025)

Table S1 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
per: Ruth Flümann (15123900)
Publicat: (2025)

Table S2 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
per: Ruth Flümann (15123900)
Publicat: (2025)

Table S3 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
per: Ruth Flümann (15123900)
Publicat: (2025)

Table S4 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
per: Ruth Flümann (15123900)
Publicat: (2025)

Table S5 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
per: Ruth Flümann (15123900)
Publicat: (2025)

Table S6 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
per: Ruth Flümann (15123900)
Publicat: (2025)

Sensitivity of Δ<i>Fghof1</i> mutant conidia to different DAPI concentrations.
per: Yakubu Saddeeq Abubakar (5558399)
Publicat: (2025)

Sensitivity of the SH3 domain-containing gene mutants to various stress-inducing agents.
per: Yakubu Saddeeq Abubakar (5558399)
Publicat: (2025)

Data Sheet 2_Transcriptome-wide prediction of heat-sensitive RNA structures in Zea mays.pdf
per: Mason W. Eisenhauer (22687085)
Publicat: (2025)

Data Sheet 1_Transcriptome-wide prediction of heat-sensitive RNA structures in Zea mays.pdf
per: Mason W. Eisenhauer (22687085)
Publicat: (2025)

Supplementary Table 1 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
per: Naoshad Muhammad (14960127)
Publicat: (2025)

Supplementary Table 2 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
per: Naoshad Muhammad (14960127)
Publicat: (2025)

Supplementary Dataset S1 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S2 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S3 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S4 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S5 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S6 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S7 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S8 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Supplementary Dataset S9 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition
per: Cara Abecunas (14960274)
Publicat: (2025)

Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
per: Emmanuel Griessinger (16721087)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_aq8et9pb038i1d6vte2lh2p3ra